Achaogen COO Promoted to Top Post, Effective Jan. 1, 2018 Post author:Sam Post published:December 11, 2017 Post category:BioPharma Dr. Hillan will remain on, and Mr. Wise will join, the Company’s Board of Directors. Source: BioSpace You Might Also Like Sinking Teva Needs a New CEO But May Need to Up Salary February 7, 2017 SAb Biotherapeutics Integrates Operations With New Production Facility August 29, 2017 Strongbridge Biopharma Banks $53 Million Financing From July 16, 2017
